Changes in DT vaccine frequency and indications for use following introduction of DTaP vaccine
- PMID: 18382136
- DOI: 10.4161/hv.4.3.5517
Changes in DT vaccine frequency and indications for use following introduction of DTaP vaccine
Abstract
Our population-based study among HMO members under seven years of age in 1993-2000 showed that frequency of diphtheria and tetanus toxoid vaccine (DT) use declined significantly following the introduction of acellular pertussis-containing (DTaP) vaccine. We also observed changes in indications for DT following the transition to DTaP among children under two years of age; notably, a decline in the proportion of children receiving DT due to a reported prior vaccine reaction and an increase in the proportion of children receiving DT due to parental request and a history of pertussis.
Similar articles
-
[Whooping cough in Spain. Current epidemiology, prevention and control strategies. Recommendations by the Pertussis Working Group].Enferm Infecc Microbiol Clin. 2013 Apr;31(4):240-53. doi: 10.1016/j.eimc.2012.12.011. Epub 2013 Feb 12. Enferm Infecc Microbiol Clin. 2013. PMID: 23411362 Review. Spanish.
-
Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2008 May 30;57(RR-4):1-51. MMWR Recomm Rep. 2008. PMID: 18509304 Review.
-
Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by different 5-dose DTaP/DTwP schedules.Clin Pediatr (Phila). 2006 Sep;45(7):613-20. doi: 10.1177/0009922806289593. Clin Pediatr (Phila). 2006. PMID: 16928838 Clinical Trial.
-
Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.Pediatrics. 2006 Mar;117(3):965-78. doi: 10.1542/peds.2005-3038. Epub 2005 Dec 28. Pediatrics. 2006. PMID: 16382131
-
A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine.Pediatrics. 1998 Jan;101(1 Pt 1):1-11. doi: 10.1542/peds.101.1.1. Pediatrics. 1998. PMID: 9417143 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical